Nylex (Malaysia) Berhad Past Earnings Performance
Past criteria checks 0/6
Nylex (Malaysia) Berhad has been growing earnings at an average annual rate of 23.1%, while the Chemicals industry saw earnings growing at 7.7% annually. Revenues have been declining at an average rate of 66.5% per year.
Key information
23.1%
Earnings growth rate
23.2%
EPS growth rate
| Chemicals Industry Growth | 8.9% |
| Revenue growth rate | -66.5% |
| Return on equity | -11.9% |
| Net Margin | -874.9% |
| Last Earnings Update | 29 Feb 2024 |
Recent past performance updates
Recent updates
Is Nylex (Malaysia) Berhad (KLSE:NYLEX) Using Too Much Debt?
Dec 27
Nylex (Malaysia) Berhad (KLSE:NYLEX) Seems To Use Debt Quite Sensibly
Sep 21We Think Nylex (Malaysia) Berhad (KLSE:NYLEX) Is Taking Some Risk With Its Debt
May 06We Think Nylex (Malaysia) Berhad (KLSE:NYLEX) Has A Fair Chunk Of Debt
Jan 15
Here's What We Learned About The CEO Pay At Nylex (Malaysia) Berhad (KLSE:NYLEX)
Nov 23Revenue & Expenses Breakdown
How Nylex (Malaysia) Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 29 Feb 24 | 0 | -2 | 3 | 0 |
| 30 Nov 23 | 0 | -2 | 2 | 0 |
| 31 Aug 23 | 0 | -2 | 2 | 0 |
| 31 May 23 | 0 | -2 | 2 | 0 |
| 28 Feb 23 | -934 | 48 | -62 | 0 |
| 30 Nov 22 | -660 | -10 | -45 | 0 |
| 31 Aug 22 | -275 | -1 | -16 | 0 |
| 31 May 22 | 0 | -1 | 1 | 0 |
| 28 Feb 22 | 136 | -58 | 1 | 0 |
| 30 Nov 21 | 151 | 4 | 7 | 0 |
| 31 Aug 21 | 29 | 1 | -2 | 0 |
| 31 May 21 | 0 | -1 | 1 | 0 |
| 28 Feb 21 | 1,029 | -11 | 87 | 0 |
| 30 Nov 20 | 1,015 | -19 | 90 | 0 |
| 31 Aug 20 | 1,068 | -24 | 96 | 0 |
| 31 May 20 | 1,136 | -23 | 99 | 0 |
| 29 Feb 20 | 1,286 | -4 | 96 | 0 |
| 30 Nov 19 | 1,336 | -7 | 98 | 0 |
| 31 Aug 19 | 1,455 | -8 | 96 | 0 |
| 31 May 19 | 1,560 | -3 | 100 | 0 |
| 28 Feb 19 | 1,605 | 2 | 109 | 0 |
| 30 Nov 18 | 1,624 | 14 | 107 | 0 |
| 31 Aug 18 | 1,553 | 21 | 108 | 0 |
| 31 May 18 | 1,446 | 19 | 105 | 0 |
| 28 Feb 18 | 1,402 | 20 | 104 | 0 |
| 30 Nov 17 | 1,427 | 22 | 104 | 0 |
| 31 Aug 17 | 1,378 | 22 | 103 | 0 |
| 31 May 17 | 1,337 | 20 | 103 | 0 |
| 28 Feb 17 | 1,248 | 20 | 97 | 0 |
| 30 Nov 16 | 1,135 | 14 | 93 | 0 |
| 31 Aug 16 | 1,148 | 10 | 90 | 0 |
| 31 May 16 | 1,197 | 11 | 88 | 0 |
| 29 Feb 16 | 1,231 | 7 | 90 | 0 |
| 30 Nov 15 | 1,245 | 5 | 87 | 0 |
| 31 Aug 15 | 1,237 | 6 | 86 | 0 |
| 31 May 15 | 1,273 | 7 | 84 | 0 |
| 28 Feb 15 | 1,325 | 4 | 73 | 0 |
| 30 Nov 14 | 1,380 | 8 | 75 | 0 |
| 31 Aug 14 | 1,508 | 9 | 77 | 0 |
| 31 May 14 | 1,566 | 8 | 82 | 0 |
| 28 Feb 14 | 1,631 | 11 | 93 | 0 |
| 30 Nov 13 | 1,706 | 9 | 98 | 0 |
| 31 Aug 13 | 1,704 | 8 | 99 | 0 |
| 31 May 13 | 1,729 | 8 | 97 | 0 |
Quality Earnings: NYLEX is currently unprofitable.
Growing Profit Margin: NYLEX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NYLEX is unprofitable, but has reduced losses over the past 5 years at a rate of 23.1% per year.
Accelerating Growth: Unable to compare NYLEX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NYLEX is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (10.2%).
Return on Equity
High ROE: NYLEX has a negative Return on Equity (-11.89%), as it is currently unprofitable.